“Diversity: the art of thinking independently together”

– Malcolm Stevenson Forbes

By delivering breakthrough therapies that can harness the immune system, we aim to conquer cancer and save lives

Amunix is an immuno-oncology company leveraging our proprietary, clinically validated Pro-XTEN technology platform to discover and develop transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer. We aim to expand the therapeutic index of TCEs and cytokines, which have demonstrated anti-tumor clinical activity, but have not realized their potential due to dose-limiting on-target, off-tumor toxicity.

We address this challenge by using our universal, protease-releasable masking technology (Pro-XTEN), to create next generation, conditionally active TCEs (XPATs®) and cytokines (XPACs), that are preferentially activated in tumors as compared to healthy tissues.

Experience and culture matter. At Amunix, we challenge ourselves and our colleagues, and bring a critical eye and rigor to everything we do. Biology is complex and hard to predict, but with deep experience, diversity of thinking, and scientific rigor, we believe we maximize our chance of making a real difference for cancer patients.

Sanofi Governance page: https://www.sanofi.com/en/about-us/governance

Leadership

Executive Committee

Mika Derynck photo

Mika Kakefuda Derynck, M.D.

Chief Medical Officer

Maninder Hora photo

Maninder Hora, Ph.D.

Chief Technical Operations Officer

Darcy Mootz photo

Darcy Mootz, Ph.D.

Amunix Site Head

Volker Schellenberger photo

Volker Schellenberger, Ph.D.

President and Chief Technology Officer

Additional Senior Management

Nicky Barber photo

Nicky Barber, CPA

Senior Vice President of Finance

Kim Baxter photo

Kimberly Baxter

Vice President of Quality Assurance

theresa dewitt photo

Theresa DeWitt

Vice President of Clinical Operations

Michelle Heath photo

Michelle Heath

Head of People

Robert Jones photo

Robert Jones

Vice President of Contracts

Geetha Shankar photo

Geetha Shankar, Ph.D.

Senior Vice President of Clinical Science and Clinical Operations

Gary Taniguchi photo

Gary T. Taniguchi, Ph.D.

VICE PRESIDENT OF BIOANALYTICAL SCIENCES

Code of Ethics

Compliance Helpline

Allows confidential, anonymous reporting of concerns that may violate our Company Code of Ethics, policies or law and is available to NA personnel 24/7.

Visit https://sanofi.ethicspoint.com or call 1-800-648-1297.